Vaccines for the future: Learning from human immunology

Microbial Biotechnology

Volumn 5, Issue 2, 2012, Pages 149-155

  De Gregorio, Ennio ^a   Rappuoli, Rino ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS VECTOR; WATER OIL CREAM; YELLOW FEVER VACCINE;

ADAPTIVE IMMUNITY; CONFORMATIONAL TRANSITION; CYTOMEGALOVIRUS INFECTION; DNA MICROARRAY; DRUG EFFICACY; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOASSAY; MENINGOCOCCOSIS; MICROBIAL DIVERSITY; MUTATION RATE; NONHUMAN; PANDEMIC INFLUENZA; PNEUMOCOCCAL INFECTION; PROTEIN EXPRESSION; SHORT SURVEY; SYSTEMS BIOLOGY; VACCINATION; YELLOW FEVER;

ALLERGY AND IMMUNOLOGY; BIOTECHNOLOGY; COMMUNICABLE DISEASE CONTROL; GENOMICS; HUMANS; SYSTEMS BIOLOGY; VACCINES;

EID: 83655180680     PISSN: 17517907     EISSN: 17517915     Source Type: Journal    
DOI: 10.1111/j.1751-7915.2011.00276.x     Document Type: Short Survey

References (49)

1. Bachmann, M.F., and Jennings, G.T. (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 10: 787-796.
2. Banzhoff, A., Gasparini, R., Laghi-Pasini, F., Staniscia, T., Durando, P., Montomoli, E., etal. (2009) MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. PLoS ONE 4: e4384.
3. Buchbinder, S.P., Mehrotra, D.V., Duerr, A., Fitzgerald, D.W., Mogg, R., Li, D., etal. (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881-1893.
4. Coffman, R.L., Sher, A., and Seder, R.A. (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33: 492-503.
5. Cohen, J., Nussenzweig, V., Nussenzweig, R., Vekemans, J., and Leach, A. (2010) From the circumsporozoite protein to the RTS, S/AS candidate vaccine. Hum Vaccin 6: 90-96.
6. Corti, D., Suguitan, A.L., Jr, Pinna, D., Silacci, C., Fernandez-Rodriguez, B.M., Vanzetta, F., etal. (2010) Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 120: 1663-1673.
7. Dormitzer, P.R., Galli, G., Castellino, F., Golding, H., Khurana, S., Del Giudice, G., and Rappuoli, R. (2011) Influenza vaccine immunology. Immunol Rev 239: 167-177.
8. Drane, D., Gittleson, C., Boyle, J., and Maraskovsky, E. (2007) ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines. Expert Rev Vaccines 6: 761-772.
9. Drane, D., Maraskovsky, E., Gibson, R., Mitchell, S., Barnden, M., Moskwa, A., etal. (2009) Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers. Hum Vaccin 5: 151-157.
10. Duggan, S.T. (2010) Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13(R)]. Drugs 70: 1973-1986.
11. Ekiert, D.C., Bhabha, G., Elsliger, M.A., Friesen, R.H., Jongeneelen, M., Throsby, M., etal. (2009) Antibody recognition of a highly conserved influenza virus epitope. Science 324: 246-251.
12. Findlow, J., Borrow, R., Snape, M.D., Dawson, T., Holland, A., John, T.M., etal. (2010) Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin Infect Dis 51: 1127-1137.
13. Galli, G., Hancock, K., Hoschler, K., DeVos, J., Praus, M., Bardelli, M., etal. (2009a) Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. Proc Natl Acad Sci USA 106: 7962-7967.
14. Galli, G., Medini, D., Borgogni, E., Zedda, L., Bardelli, M., Malzone, C., etal. (2009b) Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc Natl Acad Sci USA 106: 3877-3882.
15. Gaucher, D., Therrien, R., Kettaf, N., Angermann, B.R., Boucher, G., Filali-Mouhim, A., etal. (2008) Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med 205: 3119-3131.
16. Germain, R.N. (2010) Vaccines and the future of human immunology. Immunity 33: 441-450.
17. Giannini, S.L., Hanon, E., Moris, P., Van Mechelen, M., Morel, S., Dessy, F., etal. (2006) Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only. Vaccine 24: 5937-5949.
18. Giuliani, M.M., Adu-Bobie, J., Comanducci, M., Arico, B., Savino, S., Santini, L., etal. (2006) A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci USA 103: 10834-10839.
19. Khurana, S., Chearwae, W., Castellino, F., Manischewitz, J., King, L.R., Honorkiewicz, A., etal. (2010) Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci Transl Med 2: 15ra15.
20. Krutzik, P.O., Trejo, A., Schulz, K.R., and Nolan, G.P. (2011) Phospho flow cytometry methods for the analysis of kinase signaling in cell lines and primary human blood samples. Methods Mol Biol 699: 179-202.
21. Lauer, P., Rinaudo, C.D., Soriani, M., Margarit, I., Maione, D., Rosini, R., etal. (2005) Genome analysis reveals pili in Group B Streptococcus. Science 309: 105.
22. Levine, M.M., Dougan, G., Good, M.F., Liu, M.A., Nabel, G.J., Nataro, J.P., and Rappuoli, R. (2009) New Generation Vaccines, 4th edn. New York, USA: Informa Health Care USA.
23. Liao, H.X., Levesque, M.C., Nagel, A., Dixon, A., Zhang, R., Walter, E., etal. (2009) High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J Virol Methods 158: 171-179.
24. Liu, M.A. (2010) Immunologic basis of vaccine vectors. Immunity 33: 504-515.
25. Macagno, A., Bernasconi, N.L., Vanzetta, F., Dander, E., Sarasini, A., Revello, M.G., etal. (2010) Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. J Virol 84: 1005-1013.
26. McElrath, M.J., and Haynes, B.F. (2010) Induction of immunity to human immunodeficiency virus type-1 by vaccination. Immunity 33: 542-554.
27. McElrath, M.J., De Rosa, S.C., Moodie, Z., Dubey, S., Kierstead, L., Janes, H., etal. (2008) HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372: 1894-1905.
28. Maione, D., Margarit, I., Rinaudo, C.D., Masignani, V., Mora, M., Scarselli, M., etal. (2005) Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309: 148-150.
29. Mbow, M.L., De Gregorio, E., Valiante, N.M., and Rappuoli, R. (2010) New adjuvants for human vaccines. Curr Opin Immunol 22: 411-416.
30. Nabel, G.J., and Fauci, A.S. (2010) Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine. Nat Med 16: 1389-1391.
31. Pace, D. (2009) Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy. Expert Rev Vaccines 8: 529-542.
32. Plotkin, S., Orenstein, W., and Offit, P.A. (2008) Vaccines, 5th edn. Philadelphia, PA, USA: Saunders.
33. Pomfret, T.C., Gagnon, J.M., Jr, and Gilchrist, A.T. (2011) Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics. J Clin Pharm Ther 36: 1-9.
34. Prymula, R., and Schuerman, L. (2009) 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix. Expert Rev Vaccines 8: 1479-1500.
35. Pulendran, B., Li, S., and Nakaya, H.I. (2010) Systems vaccinology. Immunity 33: 516-529.
36. Querec, T.D., Akondy, R.S., Lee, E.K., Cao, W., Nakaya, H.I., Teuwen, D., etal. (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10: 116-125.
37. Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., etal. (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-2220.
38. Sallusto, F., Lanzavecchia, A., Araki, K., and Ahmed, R. (2010) From vaccines to memory and back. Immunity 33: 451-463.
39. Scarselli, M., Aricò, B., Brunelli, B., Savino, S., Di Marcello, F., Palumbo, E., etal. (2011) Rational design and structure of a meningococcal antigen inducing broad protective immunity. Sci Transl Med, in press.
40. Scheid, J.F., Mouquet, H., Feldhahn, N., Seaman, M.S., Velinzon, K., Pietzsch, J., etal. (2009) Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458: 636-640.
41. Schwarz, T.F., Horacek, T., Knuf, M., Damman, H.G., Roman, F., Drame, M., etal. (2009) Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. Vaccine 27: 6284-6290.
42. Sette, A., and Rappuoli, R. (2010) Reverse vaccinology: developing vaccines in the era of genomics. Immunity 33: 530-541.
43. Snape, M.D., Dawson, T., Oster, P., Evans, A., John, T.M., Ohene-Kena, B., etal. (2010) Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial. Pediatr Infect Dis J 29: e71-e79.
44. Steinhagen, F., Kinjo, T., Bode, C., and Klinman, D.M. (2010) TLR-based immune adjuvants. Vaccine 29: 3341-3355.
45. Sui, J., Hwang, W.C., Perez, S., Wei, G., Aird, D., Chen, L.M., etal. (2009) Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16: 265-273.
46. Sun, H.X., Xie, Y., and Ye, Y.P. (2009) ISCOMs and ISCOMATRIX. Vaccine 27: 4388-4401.
47. Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M.R., etal. (2004) An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 10: 871-875.
48. Wrammert, J., Smith, K., Miller, J., Langley, W.A., Kokko, K., Larsen, C., etal. (2008) Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 453: 667-671.
49. Wu, X., Yang, Z.Y., Li, Y., Hogerkorp, C.M., Schief, W.R., Seaman, M.S., etal. (2010) Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329: 856-861.